BEONE MEDICINES LTD-ADR (ONC) Stock Earnings & Estimates
USA - NASDAQ:ONC - US07725L1026 - ADR
326.06 USD
-2.65 (-0.81%)
326.06 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 9.566B 26.06% | 17.423B 82.13% | 27.214B 56.19% | 37.981B 39.56% | 45.428B 19.61% | 51.166B 12.63% | 57.617B 12.61% | 63.772B 10.68% | 71.095B 11.48% | 75.889B 6.74% | 78.673B 3.67% | |
| EBITDA YoY % growth | N/A -38.91% | N/A 26.94% | N/A 56.75% | 1.743B 150.24% | 5.51B 216.12% | 8.93B 62.07% | 19.551B 118.94% | 26.179B 33.90% | 31.491B 20.29% | 36.614B 16.27% | 30.22B -17.46% | |
| EBIT YoY % growth | -12.026B -27.00% | -8.751B 27.23% | -4.242B 51.53% | 449.4M 110.59% | 4.601B 923.81% | 6.557B 42.51% | 13.539B 106.48% | 16.587B 22.51% | 21.191B 27.76% | 23.778B 12.21% | 25.313B 6.46% | |
| Operating Margin | -125.71% | -50.22% | -15.59% | 1.18% | 10.13% | 12.82% | 23.50% | 26.01% | 29.81% | 31.33% | 32.17% | |
| EPS YoY % growth | -132.88 45.69% | -60.54 54.44% | -47.51 21.52% | 10.20 121.46% | 35.88 251.89% | 60.01 67.24% | 1,075.25 1,691.82% | 1,227.98 14.20% | 1,630.99 32.82% | 1,504.46 -7.76% | 2,005.29 33.29% |
All data in CNY
| Q3 / 25 | Q4 / 25 | |
|---|---|---|
| EPS Q2Q % growth | 7.91 193.95% | 3.82 -98.71% |
| Revenue Q2Q % growth | 10.244B 42.75% | 10.634B 34.47% |
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | 924.71M 208.00% | 706.24M 220.67% |
All data in CNY
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 5.09 104.68% | 0.40 | 4.70 | 1,187.13% |
| Q1 2025 Q2Q % growth | 115.08 150.90% | -3.82 | 118.90 | 3,109.85% |
| Q4 2024 Q2Q % growth | 295.68 1,260.99% | 15.56 | 280.12 | 1,800.57% |
| Q3 2024 Q2Q % growth | -8.42 -159.34% | -6.86 | -1.56 | -22.81% |
| Q2 2024 Q2Q % growth | -108.70 -323.98% | -12.00 | -96.70 | -805.99% |
| Q1 2024 Q2Q % growth | -226.07 -856.85% | -20.57 | -205.51 | -999.20% |
| Q4 2023 Q2Q % growth | -25.47 18.03% | -10.81 | -14.66 | -135.57% |
| Q3 2023 Q2Q % growth | 14.19 138.68% | -24.79 | 38.98 | 157.25% |
| Q2 2023 Q2Q % growth | -25.64 30.85% | -23.73 | -1.91 | -8.03% |
| Q1 2023 Q2Q % growth | -23.63 15.81% | -23.34 | -0.29 | -1.25% |
| Q4 2022 Q2Q % growth | -31.07 25.20% | -12.39 | -18.67 | -150.68% |
| Q3 2022 Q2Q % growth | -36.68 | -36.78 | 0.10 | 0.28% |
| Q2 2022 Q2Q % growth | -37.07 | -29.00 | -8.07 | -27.81% |
| Q1 2022 Q2Q % growth | -28.07 | -24.92 | -3.15 | -12.63% |
| Q4 2021 Q2Q % growth | -41.54 | -33.22 | -8.31 | -25.02% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 9.47B 40.76% | 8.91B | 560.399M | 6.29% |
| Q1 2025 Q2Q % growth | 8.074B 50.65% | 8.176B | -102.423M | -1.25% |
| Q4 2024 Q2Q % growth | 7.908B 73.88% | 7.496B | 412.084M | 5.50% |
| Q3 2024 Q2Q % growth | 7.176B 27.60% | 7.158B | 18.363M | 0.26% |
| Q2 2024 Q2Q % growth | 6.728B 60.77% | 5.255B | 1.473B | 28.03% |
| Q1 2024 Q2Q % growth | 5.359B 74.78% | 4.557B | 802.338M | 17.61% |
| Q4 2023 Q2Q % growth | 4.548B 68.60% | 4.07B | 478.108M | 11.75% |
| Q3 2023 Q2Q % growth | 5.624B 111.55% | 4.108B | 1.516B | 36.90% |
| Q2 2023 Q2Q % growth | 4.185B 84.97% | 3.256B | 928.839M | 28.53% |
| Q1 2023 Q2Q % growth | 3.066B 57.42% | 2.897B | 169.389M | 5.85% |
| Q4 2022 Q2Q % growth | 2.698B 98.00% | 2.44B | 257.639M | 10.56% |
| Q3 2022 Q2Q % growth | 2.659B 99.05% | 2.406B | 252.516M | 10.50% |
| Q2 2022 Q2Q % growth | 2.262B 135.16% | 2.048B | 214.396M | 10.47% |
| Q1 2022 Q2Q % growth | 1.948B -50.42% | 1.838B | 109.858M | 5.98% |
| Q4 2021 Q2Q % growth | 1.362B 105.94% | 1.413B | -50.562M | -3.58% |
| Q3 2021 Q2Q % growth | 1.336B -8.44% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 14.94% | N/A | 14.94% | 135.01% |
| Revenue | 0% | N/A | 2.18% | 2.85% |